glp 1 and neck pain Does GLP-1 Cause Back Pain? Evidence Management GLP-1 Weight Loss Drugs: Be

Grech O, Mitchell JL, Lyons HS, Yiangou A, Thaller M, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ (2024) Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in idiopathic intracranial hypertension

CHAIN MODIFIED POLYPEPTIDES", USED PRIMARILY AS HORMONES, HS CODE2934, 2020-2024, VOLUME (TON 126 TABLE 37 MANUFACTURING SITES OF KEY API SUPPLIERS 128 TABLE 38 LIST OF SITE EXPANSIONS FOR API MANUFACTURERS, 20232025 130 TABLE 39 KEY COMPANIES IMPLEMENTING AI 133 TABLE 40 US ADJUSTED RECIPROCAL TARIFF RATES 134 TABLE 41 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 139 TABLE 42 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 139 TABLE 43 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 140 TABLE 44 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY REGION, 20232030 (USD BILLION) 141 TABLE 45 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 141 TABLE 46 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 142 TABLE 47 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 142 TABLE 48 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 143 TABLE 49 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 143 TABLE 50 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE APIS, BY COUNTRY, 20232030 (USD BILLION) 143 TABLE 51 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY REGION, 20232030 (USD BILLION) 144 TABLE 52 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 145 TABLE 53 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 145 TABLE 54 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 146 TABLE 55 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 146 TABLE 56 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 146 TABLE 57 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC APIS, BY COUNTRY, 20232030 (USD BILLION) 147 TABLE 58 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 149 TABLE 59 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 149 TABLE 60 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 150 TABLE 61 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY REGION, 20232030 (USD BILLION) 151 TABLE 62 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 151 TABLE 63 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 152 TABLE 64 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 152 TABLE 65 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 153 TABLE 66 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 153 TABLE 67 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR TRADITIONAL APIS, BY COUNTRY, 20232030 (USD BILLION) 153 TABLE 68 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY TYPE, 20232030 (USD BILLION) 154 TABLE 69 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY REGION, 20232030 (USD BILLION) 155 TABLE 70 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 155 TABLE 71 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 156 TABLE 72 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 156 TABLE 73 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 157 TABLE 74 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 157 TABLE 75 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT APIS, BY COUNTRY, 20232030 (USD BILLION) 157 TABLE 76 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY REGION, 20232030 (USD BILLION) 158 TABLE 77 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 159 TABLE 78 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 159 TABLE 79 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 160 TABLE 80 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 160 TABLE 81 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 160 TABLE 82 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HIGHLY POTENT SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 161 TABLE 83 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY REGION, 20232030 (USD BILLION) 162 TABLE 84 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 162 TABLE 85 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 163 TABLE 86 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 163 TABLE 87 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 164 TABLE 88 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 164 TABLE 89 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOLOGICS, BY COUNTRY, 20232030 (USD BILLION) 164 TABLE 90 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 (USD BILLION) 166 TABLE 91 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 166 TABLE 92 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 (USD BILLION) 167 TABLE 93 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 20232030 (USD BILLION) 168 TABLE 94 NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 168 TABLE 95 EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 169 TABLE 96 ASIA PACIFIC: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 169 TABLE 97 LATIN AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 170 TABLE 98 MIDDLE EAST: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 170 TABLE 99 GCC COUNTRIES: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 170 TABLE 100 SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 171 TABLE 101 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY REGION, 20232030 (USD BILLION) 172 TABLE 102 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 172 TABLE 103 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 173 TABLE 104 ASIA PACIFIC: INACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 173 TABLE 105 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 174 TABLE 106 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 174 TABLE 107 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 174 TABLE 108 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY REGION, 20232030 (USD BILLION) 175 TABLE 109 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 176 TABLE 110 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 176 TABLE 111 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 177 TABLE 112 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 177 TABLE 113 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 178 TABLE 114 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC SYNTHETIC APIS, BY COUNTRY, 20232030 (USD BILLION) 178 TABLE 115 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY REGION, 20232030 (USD BILLION) 179 TABLE 116 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 179 TABLE 117 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 180 TABLE 118 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 180 TABLE 119 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 181 TABLE 120 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 181 TABLE 121 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 181 TABLE 122 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 182 TABLE 123 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY REGION, 20232030 (USD BILLION) 183 TABLE 124 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 183 TABLE 125 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 184 TABLE 126 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 184 TABLE 127 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 185 TABLE 128 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 185 TABLE 129 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INNOVATIVE BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 185 TABLE 130 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY REGION, 20232030 (USD BILLION) 187 TABLE 131 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 187 TABLE 132 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 188 TABLE 133 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 188 TABLE 134 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 189 TABLE 135 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 189 TABLE 136 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR GENERIC BIOTECH APIS, BY COUNTRY, 20232030 (USD BILLION) 189 TABLE 137 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 190 TABLE 138 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 20232030 (USD BILLION) 191 TABLE 139 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 191 TABLE 140 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 192 TABLE 141 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 192 TABLE 142 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 193 TABLE 143 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 193 TABLE 144 GCC COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 20232030 (USD BILLION) 193 TABLE 145 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY REGION, 20232030 (USD BILLION) 194 TABLE 146 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 194 TABLE 147 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 195 TABLE 148 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 195 TABLE 149 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 196 TABLE 150 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 196 TABLE 151 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES AND GROWTH FACTORS, BY COUNTRY, 20232030 (USD BILLION) 196 TABLE 152 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 20232030 (USD BILLION) 197 TABLE 153 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 197 TABLE 154 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 198 TABLE 155 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 198 TABLE 156 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 199 TABLE 157 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 199 TABLE 158 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 20232030 (USD BILLION) 199 TABLE 159 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 20232030 (USD BILLION) 200 TABLE 160 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 200 TABLE 161 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 201 TABLE 162 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 201 TABLE 163 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 202 TABLE 164 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 202 TABLE 165 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 20232030 (USD BILLION) 202 TABLE 166 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 20232030 (USD BILLION) 203 TABLE 167 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 203 TABLE 168 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 204 TABLE 169 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 204 TABLE 170 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 205 TABLE 171 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 205 TABLE 172 GCC COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 20232030 (USD BILLION) 205 TABLE 173 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY REGION, 20232030 (USD BILLION) 206 TABLE 174 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 206 TABLE 175 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 207 TABLE 176 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 207 TABLE 177 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 208 TABLE 178 MIDDLE EAST: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 208 TABLE 179 GCC COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS AND ANTI-COAGULANTS, BY COUNTRY, 20232030 (USD BILLION) 208 TABLE 180 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 20232030 (USD BILLION) 209 TABLE 181 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 210 TABLE 182 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 210 TABLE 183 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 211 TABLE 184 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 211 TABLE 185 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 212 TABLE 186 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 20232030 (USD BILLION) 212 TABLE 187 BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 213 TABLE 188 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 20232030 (USD BILLION) 214 TABLE 189 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 214 TABLE 190 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 215 TABLE 191 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 215 TABLE 192 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 216 TABLE 193 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 216 TABLE 194 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 216 TABLE 195 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 20232030 (USD BILLION) 217 TABLE 196 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 218 TABLE 197 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 218 TABLE 198 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 219 TABLE 199 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 219 TABLE 200 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 220 TABLE 201 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 220 TABLE 202 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 20232030 (USD BILLION) 221 TABLE 203 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 221 TABLE 204 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 222 TABLE 205 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 222 TABLE 206 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 223 TABLE 207 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 223 TABLE 208 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 223 TABLE 209 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 20232030 (USD BILLION) 225 TABLE 210 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 225 TABLE 211 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 226 TABLE 212 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 226 TABLE 213 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 227 TABLE 214 MIDDLE EAST: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 227 TABLE 215 GCC COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 227 TABLE 216 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 20232030 (USD BILLION) 228 TABLE 217 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 228 TABLE 218 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 229 TABLE 219 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 229 TABLE 220 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 230 TABLE 221 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 230 TABLE 222 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 20232030 (USD BILLION) 230 TABLE 223 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 232 TABLE 224 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 232 TABLE 225 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 233 TABLE 226 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY REGION, 20232030 (USD BILLION) 234 TABLE 227 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 234 TABLE 228 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 235 TABLE 229 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 235 TABLE 230 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 236 TABLE 231 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 236 TABLE 232 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PRESCRIPTION DRUGS, BY COUNTRY, 20232030 (USD BILLION) 236 TABLE 233 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY REGION, 20232030 (USD BILLION) 237 TABLE 234 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 238 TABLE 235 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER- THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 238 TABLE 236 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 239 TABLE 237 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 239 TABLE 238 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 239 TABLE 239 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OVER-THE-COUNTER DRUGS, BY COUNTRY, 20232030 (USD BILLION) 240 TABLE 240 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 242 TABLE 241 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 243 TABLE 242 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 243 TABLE 243 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 20232030 (USD BILLION) 244 TABLE 244 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 245 TABLE 245 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 245 TABLE 246 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 246 TABLE 247 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 246 TABLE 248 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 247 TABLE 249 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 20232030 (USD BILLION) 247 TABLE 250 LIST OF FDA-APPROVED DRUGS FOR DIFFERENT TYPES OF CANCER 248 TABLE 251 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 20232030 (USD BILLION) 248 TABLE 252 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 249 TABLE 253 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 249 TABLE 254 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 250 TABLE 255 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 250 TABLE 256 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 250 TABLE 257 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 20232030 (USD BILLION) 251 TABLE 258 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY REGION, 20232030 (USD BILLION) 252 TABLE 259 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 252 TABLE 260 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 253 TABLE 261 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 253 TABLE 262 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 254 TABLE 263 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 254 TABLE 264 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 20232030 (USD BILLION) 254 TABLE 265 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 20232030 (USD BILLION) 255 TABLE 266 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 256 TABLE 267 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 256 TABLE 268 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 257 TABLE 269 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 257 TABLE 270 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 257 TABLE 271 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 20232030 (USD BILLION) 258 TABLE 272 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 20232030 (USD BILLION) 259 TABLE 273 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 259 TABLE 274 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 260 TABLE 275 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 260 TABLE 276 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 261 TABLE 277 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 261 TABLE 278 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 20232030 (USD BILLION) 261 TABLE 279 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 20232030 (USD BILLION) 262 TABLE 280 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 263 TABLE 281 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 263 TABLE 282 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 264 TABLE 283 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 264 TABLE 284 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 264 TABLE 285 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 20232030 (USD BILLION) 265 TABLE 286 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 20232030 (USD BILLION) 266 TABLE 287 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 266 TABLE 288 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 267 TABLE 289 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 267 TABLE 290 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 268 TABLE 291 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 268 TABLE 292 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 20232030 (USD BILLION) 268 TABLE 293 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 270 TABLE 294 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 271 TABLE 295 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 271 TABLE 296 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY REGION, 20232030 (USD BILLION) 272 TABLE 297 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 273 TABLE 298 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 273 TABLE 299 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 274 TABLE 300 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 274 TABLE 301 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 274 TABLE 302 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRY, BY COUNTRY, 20232030 (USD BILLION) 275 TABLE 303 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 20232030 (USD BILLION) 276 TABLE 304 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 276 TABLE 305 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 277 TABLE 306 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 277 TABLE 307 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 278 TABLE 308 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 278 TABLE 309 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 278 TABLE 310 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 20232030 (USD BILLION) 279 TABLE 311 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 280 TABLE 312 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 280 TABLE 313 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 281 TABLE 314 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 281 TABLE 315 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 281 TABLE 316 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 20232030 (USD BILLION) 282 TABLE 317 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY REGION, 20232030 (USD BILLION) 283 TABLE 318 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 283 TABLE 319 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 284 TABLE 320 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 284 TABLE 321 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 285 TABLE 322 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 285 TABLE 323 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER END USERS, BY COUNTRY, 20232030 (USD BILLION) 285 TABLE 324 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 20232030 (USD BILLION) 287 TABLE 325 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION (CAPTIVE AND MERCHANT), 20232030 (USD BILLION) 288 TABLE 326 CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 20232030 (USD BILLION) 288 TABLE 327 NORTH AMERICA: KEY MACROECONOMIC INDICATORS 290 TABLE 328 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 291 TABLE 329 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 291 TABLE 330 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 291 TABLE 331 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 292 TABLE 332 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 292 TABLE 333 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 292 TABLE 334 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 293 TABLE 335 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 293 TABLE 336 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 294 TABLE 337 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 294 TABLE 338 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 295 TABLE 339 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 295 TABLE 340 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 296 TABLE 341 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 297 TABLE 342 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 297 TABLE 343 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 297 TABLE 344 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 298 TABLE 345 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 298 TABLE 346 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 299 TABLE 347 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 299 TABLE 348 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 300 TABLE 349 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 300 TABLE 350 US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 301 TABLE 351 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 302 TABLE 352 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 302 TABLE 353 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 302 TABLE 354 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 303 TABLE 355 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 303 TABLE 356 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 303 TABLE 357 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 304 TABLE 358 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 304 TABLE 359 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 305 TABLE 360 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 305 TABLE 361 CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 306 TABLE 362 EUROPE: KEY MACROECONOMIC INDICATORS 307 TABLE 363 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 308 TABLE 364 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 308 TABLE 365 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 308 TABLE 366 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 309 TABLE 367 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 309 TABLE 368 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 309 TABLE 369 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 310 TABLE 370 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 310 TABLE 371 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 311 TABLE 372 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 311 TABLE 373 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 312 TABLE 374 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 312 TABLE 375 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 313 TABLE 376 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 314 TABLE 377 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 314 TABLE 378 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 314 TABLE 379 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 315 TABLE 380 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 315 TABLE 381 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 316 TABLE 382 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 316 TABLE 383 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 317 TABLE 384 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 317 TABLE 385 GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 318 TABLE 386 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 319 TABLE 387 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 319 TABLE 388 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 319 TABLE 389 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 320 TABLE 390 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 320 TABLE 391 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 320 TABLE 392 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 321 TABLE 393 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 321 TABLE 394 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 322 TABLE 395 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 322 TABLE 396 UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 323 TABLE 397 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 324 TABLE 398 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 324 TABLE 399 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 324 TABLE 400 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 325 TABLE 401 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 325 TABLE 402 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 325 TABLE 403 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 326 TABLE 404 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 326 TABLE 405 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 327 TABLE 406 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 327 TABLE 407 FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 328 TABLE 408 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 328 TABLE 409 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 329 TABLE 410 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 329 TABLE 411 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 329 TABLE 412 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 330 TABLE 413 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 330 TABLE 414 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 331 TABLE 415 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 331 TABLE 416 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 332 TABLE 417 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 332 TABLE 418 ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 333 TABLE 419 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 334 TABLE 420 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 334 TABLE 421 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 334 TABLE 422 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 335 TABLE 423 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 335 TABLE 424 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 335 TABLE 425 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 336 TABLE 426 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 336 TABLE 427 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 337 TABLE 428 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 337 TABLE 429 SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 338 TABLE 430 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 339 TABLE 431 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 339 TABLE 432 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 339 TABLE 433 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 340 TABLE 434 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 340 TABLE 435 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 340 TABLE 436 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 341 TABLE 437 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 341 TABLE 438 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 342 TABLE 439 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 342 TABLE 440 HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 343 TABLE 441 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 344 TABLE 442 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 344 TABLE 443 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 344 TABLE 444 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 345 TABLE 445 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 345 TABLE 446 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 345 TABLE 447 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 346 TABLE 448 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 346 TABLE 449 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 347 TABLE 450 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 347 TABLE 451 REST OF EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 348 TABLE 452 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 350 TABLE 453 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 350 TABLE 454 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 351 TABLE 455 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 351 TABLE 456 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 351 TABLE 457 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 352 TABLE 458 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 352 TABLE 459 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 352 TABLE 460 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 353 TABLE 461 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 353 TABLE 462 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 354 TABLE 463 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 354 TABLE 464 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 355 TABLE 465 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 356 TABLE 466 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 356 TABLE 467 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 356 TABLE 468 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 357 TABLE 469 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 357 TABLE 470 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 357 TABLE 471 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 358 TABLE 472 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 358 TABLE 473 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 359 TABLE 474 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 359 TABLE 475 CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 360 TABLE 476 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 361 TABLE 477 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 361 TABLE 478 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 361 TABLE 479 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 362 TABLE 480 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 362 TABLE 481 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 362 TABLE 482 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 363 TABLE 483 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 363 TABLE 484 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 364 TABLE 485 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 364 TABLE 486 JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 365 TABLE 487 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 366 TABLE 488 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 366 TABLE 489 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 366 TABLE 490 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 367 TABLE 491 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 367 TABLE 492 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 367 TABLE 493 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 368 TABLE 494 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 368 TABLE 495 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 369 TABLE 496 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 369 TABLE 497 INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 370 TABLE 498 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 371 TABLE 499 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 371 TABLE 500 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 371 TABLE 501 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 372 TABLE 502 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 372 TABLE 503 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 372 TABLE 504 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 373 TABLE 505 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 373 TABLE 506 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 374 TABLE 507 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 374 TABLE 508 SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 375 TABLE 509 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 376 TABLE 510 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 376 TABLE 511 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 376 TABLE 512 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 377 TABLE 513 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 377 TABLE 514 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 377 TABLE 515 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 378 TABLE 516 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 378 TABLE 517 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 379 TABLE 518 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 379 TABLE 519 AUSTRALIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 380 TABLE 520 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 381 TABLE 521 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 381 TABLE 522 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 381 TABLE 523 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 382 TABLE 524 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 382 TABLE 525 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 382 TABLE 526 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 383 TABLE 527 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 383 TABLE 528 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 384 TABLE 529 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 384 TABLE 530 REST OF ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 385 TABLE 531 LATIN AMERICA: KEY MACRO INDICATORS 386 TABLE 532 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 386 TABLE 533 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 387 TABLE 534 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 387 TABLE 535 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 387 TABLE 536 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 388 TABLE 537 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 388 TABLE 538 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 388 TABLE 539 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 389 TABLE 540 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 389 TABLE 541 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 390 TABLE 542 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 390 TABLE 543 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 391 TABLE 544 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 392 TABLE 545 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 392 TABLE 546 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 392 TABLE 547 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 393 TABLE 548 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 393 TABLE 549 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 393 TABLE 550 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 394 TABLE 551 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 394 TABLE 552 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 395 TABLE 553 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 395 TABLE 554 BRAZIL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 396 TABLE 555 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 397 TABLE 556 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 397 TABLE 557 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 397 TABLE 558 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 398 TABLE 559 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 398 TABLE 560 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 398 TABLE 561 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 399 TABLE 562 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 399 TABLE 563 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 400 TABLE 564 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 400 TABLE 565 MEXICO: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 401 TABLE 566 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 401 TABLE 567 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 402 TABLE 568 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 402 TABLE 569 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 402 TABLE 570 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 403 TABLE 571 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 403 TABLE 572 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 404 TABLE 573 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 404 TABLE 574 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 405 TABLE 575 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 405 TABLE 576 REST OF LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 406 TABLE 577 MIDDLE EAST: KEY MACROECONOMIC INDICATORS 407 TABLE 578 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 407 TABLE 579 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 408 TABLE 580 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 408 TABLE 581 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 408 TABLE 582 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 409 TABLE 583 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 409 TABLE 584 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 409 TABLE 585 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 410 TABLE 586 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 410 TABLE 587 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 411 TABLE 588 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 411 TABLE 589 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 412 TABLE 590 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 412 TABLE 591 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 413 TABLE 592 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 413 TABLE 593 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 413 TABLE 594 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 414 TABLE 595 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 414 TABLE 596 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 415 TABLE 597 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 415 TABLE 598 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 416 TABLE 599 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 416 TABLE 600 ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 417 TABLE 601 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 20232030 (USD BILLION) 417 TABLE 602 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 418 TABLE 603 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 418 TABLE 604 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 418 TABLE 605 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 419 TABLE 606 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 419 TABLE 607 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 419 TABLE 608 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 420 TABLE 609 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 420 TABLE 610 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 421 TABLE 611 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 421 TABLE 612 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 422 TABLE 613 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 423 TABLE 614 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 423 TABLE 615 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 423 TABLE 616 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 424 TABLE 617 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 424 TABLE 618 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 424 TABLE 619 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 425 TABLE 620 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 425 TABLE 621 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 426 TABLE 622 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 426 TABLE 623 SAUDI ARABIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 427 TABLE 624 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 428 TABLE 625 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 428 TABLE 626 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 428 TABLE 627 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 429 TABLE 628 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 429 TABLE 629 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 429 TABLE 630 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 430 TABLE 631 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 430 TABLE 632 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 431 TABLE 633 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 431 TABLE 634 UAE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 432 TABLE 635 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 433 TABLE 636 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 433 TABLE 637 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 433 TABLE 638 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 434 TABLE 639 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 434 TABLE 640 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 434 TABLE 641 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 435 TABLE 642 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 435 TABLE 643 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 436 TABLE 644 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 436 TABLE 645 REST OF GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 437 TABLE 646 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 438 TABLE 647 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 438 TABLE 648 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 438 TABLE 649 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 439 TABLE 650 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 439 TABLE 651 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 439 TABLE 652 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 440 TABLE 653 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 440 TABLE 654 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 441 TABLE 655 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 441 TABLE 656 REST OF MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 442 TABLE 657 AFRICA: KEY MACROECONOMIC INDICATORS 443 TABLE 658 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 20232030 (USD BILLION) 443 TABLE 659 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 20232030 (USD BILLION) 444 TABLE 660 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY HIGHLY POTENT APIS, 20232030 (USD BILLION) 444 TABLE 661 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 20232030 USD BILLION) 444 TABLE 662 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR SYNTHETIC APIS, BY TYPE, 20232030 (USD BILLION) 445 TABLE 663 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY TYPE, 20232030 (USD BILLION) 445 TABLE 664 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY PRODUCT, 20232030 (USD BILLION) 446 TABLE 665 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BIOTECH APIS, BY EXPRESSION SYSTEM, 20232030 (USD BILLION) 446 TABLE 666 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 20232030 (USD BILLION) 447 TABLE 667 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 20232030 (USD BILLION) 447 TABLE 668 AFRICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY END USER, 20232030 (USD BILLION) 448 TABLE 669 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, JANUARY 2022OCTOBER 2025 450 TABLE 670 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION 453 TABLE 671 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: REGION FOOTPRINT 461 TABLE 672 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: TYPE FOOTPRINT 462 TABLE 673 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: POTENCY FOOTPRINT 463 TABLE 674 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: THERAPEUTIC APPLICATION FOOTPRINT 464 TABLE 675 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 468 TABLE 676 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY TYPE AND REGION 470 TABLE 677 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: PRODUCT APPROVALS, JANUARY 2022OCTOBER 2025 471 TABLE 678 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DEALS, JANUARY 2022OCTOBER 2025 471 TABLE 679 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: EXPANSIONS, JANUARY 2022OCTOBER 2025 473 TABLE 680 PFIZER INC.: COMPANY OVERVIEW 476 TABLE 681 PFIZER INC.: PRODUCTS OFFERED 477 TABLE 682 PFIZER INC.: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 479 TABLE 683 DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW 481 TABLE 684 DIVI'S LABORATORIES LIMITED: PRODUCTS OFFERED 482 TABLE 685 DIVI'S LABORATORIES LIMITED: DEALS, JANUARY 2022SEPTEMBER 2025 483 TABLE 686 DIVI'S LABORATORIES LIMITED: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 484 TABLE 687 ASYMCHEM INC.: COMPANY OVERVIEW 485 TABLE 688 ASYMCHEM INC.: PRODUCTS OFFERED 486 TABLE 689 ASYMCHEM INC.: DEALS, JANUARY 2022SEPTEMBER 2025 487 TABLE 690 ASYMCHEM INC.: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 487 TABLE 691 CIPLA: COMPANY OVERVIEW 489 TABLE 692 CIPLA: PRODUCTS OFFERED 490 TABLE 693 CIPLA: DEALS, JANUARY 2022SEPTEMBER 2025 492 TABLE 694 EVONIK: COMPANY OVERVIEW 494 TABLE 695 EVONIK: PRODUCTS OFFERED 495 TABLE 696 EVONIK: DEALS, JANUARY 2022SEPTEMBER 2025 496 TABLE 697 EVONIK: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 497 TABLE 698 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY OVERVIEW 499 TABLE 699 TEVA PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS OFFERED 500 TABLE 700 TEVA PHARMACEUTICAL INDUSTRIES LTD.: OTHER DEVELOPMENTS, JANUARY 2022SEPTEMBER 2025 509 TABLE 701 SANDOZ GROUP AG: COMPANY OVERVIEW 510 TABLE 702 SANDOZ GROUP AG: PRODUCTS OFFERED 511 TABLE 703 SANDOZ GROUP AG: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 513 TABLE 704 SK INC.: COMPANY OVERVIEW 514 TABLE 705 SK INC.: PRODUCTS OFFERED 515 TABLE 706 SK INC.: DEALS, JANUARY 2022SEPTEMBER 2025 516 TABLE 707 SK INC.: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 516 TABLE 708 MERCK KGAA: COMPANY OVERVIEW 518 TABLE 709 MERCK KGAA: PRODUCTS OFFERED 519 TABLE 710 MERCK KGAA: DEALS, JANUARY 2022SEPTEMBER 2025 520 TABLE 711 MERCK KGAA: EXPANSIONS, JANUARY 2022SEPTEMBER 2025 521 TABLE 712 DR

Recall, estrogen levels begin to decline around 30 years of age in women [9, 10], so the clinical trials selected for presentation include participants who were aged 30 to over 65 years

Your cart is currently empty MitoCORE supplies key mitochondrial micronutrients and a smart combination of alpha lipoic acid, N-acetyl cysteine, and acetyl L-carnitine to boost cellular energy production

Though these medicines help in losing weight, they have side effects

Open 7 Days, 8 AM10 PM | Las Vegas Los Angeles Miami Fort Lauderdale Orange County Medical Disclaimer Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice